301 related articles for article (PubMed ID: 25864518)
1. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
Katoh M; Katoh M
Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
[TBL] [Abstract][Full Text] [Related]
3. Notch signaling dynamics in the adult healthy prostate and in prostatic tumor development.
Pedrosa AR; Graça JL; Carvalho S; Peleteiro MC; Duarte A; Trindade A
Prostate; 2016 Jan; 76(1):80-96. PubMed ID: 26419726
[TBL] [Abstract][Full Text] [Related]
4. Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system.
Chiaramonte R; Colombo M; Bulfamante G; Falleni M; Tosi D; Garavelli S; De Simone D; Vigolo E; Todoerti K; Neri A; Platonova N
Int J Biochem Cell Biol; 2015 Sep; 66():134-40. PubMed ID: 26235278
[TBL] [Abstract][Full Text] [Related]
5. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma.
Soylu H; Acar N; Ozbey O; Unal B; Koksal IT; Bassorgun I; Ciftcioglu A; Ustunel I
Pathol Oncol Res; 2016 Jan; 22(1):87-94. PubMed ID: 26341090
[TBL] [Abstract][Full Text] [Related]
7. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
8. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.
Bennani-Baiti IM; Aryee DN; Ban J; Machado I; Kauer M; Mühlbacher K; Amann G; Llombart-Bosch A; Kovar H
J Pathol; 2011 Nov; 225(3):353-63. PubMed ID: 21984123
[TBL] [Abstract][Full Text] [Related]
9. Notch signalling and voltage-gated Na+ channel activity in human prostate cancer cells: independent modulation of in vitro motility.
Scorey N; Fraser SP; Patel P; Pridgeon C; Dallman MJ; Djamgoz MB
Prostate Cancer Prostatic Dis; 2006; 9(4):399-406. PubMed ID: 16832382
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling in prostate cancer: a moving target.
Carvalho FL; Simons BW; Eberhart CG; Berman DM
Prostate; 2014 Jun; 74(9):933-45. PubMed ID: 24737393
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling activation in pediatric low-grade astrocytoma.
Brandt WD; Schreck KC; Bar EE; Taylor I; Marchionni L; Raabe E; Eberhart CG; Rodriguez FJ
J Neuropathol Exp Neurol; 2015 Feb; 74(2):121-31. PubMed ID: 25575134
[TBL] [Abstract][Full Text] [Related]
12. Gamma-secretase Inhibitor Prevents Proliferation and Migration of Ductus Arteriosus Smooth Muscle Cells through the Notch3-HES1/2/5 Pathway.
Wu JR; Yeh JL; Liou SF; Dai ZK; Wu BN; Hsu JH
Int J Biol Sci; 2016; 12(9):1063-73. PubMed ID: 27570480
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer.
Cui J; Wang Y; Dong B; Qin L; Wang C; Zhou P; Wang X; Xu H; Xue W; Fang YX; Gao WQ
Int J Cancer; 2018 Aug; 143(3):645-656. PubMed ID: 29488214
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
Gramantieri L; Giovannini C; Lanzi A; Chieco P; Ravaioli M; Venturi A; Grazi GL; Bolondi L
Liver Int; 2007 Sep; 27(7):997-1007. PubMed ID: 17696940
[TBL] [Abstract][Full Text] [Related]
15. Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cells.
Danza G; Di Serio C; Rosati F; Lonetto G; Sturli N; Kacer D; Pennella A; Ventimiglia G; Barucci R; Piscazzi A; Prudovsky I; Landriscina M; Marchionni N; Tarantini F
Mol Cancer Res; 2012 Feb; 10(2):230-8. PubMed ID: 22172337
[TBL] [Abstract][Full Text] [Related]
16. A novel hes5/hes6 circuitry of negative regulation controls Notch activity during neurogenesis.
Fior R; Henrique D
Dev Biol; 2005 May; 281(2):318-33. PubMed ID: 15893982
[TBL] [Abstract][Full Text] [Related]
17. HES6-1 and HES6-2 function through different mechanisms during neuronal differentiation.
Vilas-Boas F; Henrique D
PLoS One; 2010 Dec; 5(12):e15459. PubMed ID: 21151987
[TBL] [Abstract][Full Text] [Related]
18. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
19. The notch signaling system is present in the postnatal pituitary: marked expression and regulatory activity in the newly discovered side population.
Chen J; Crabbe A; Van Duppen V; Vankelecom H
Mol Endocrinol; 2006 Dec; 20(12):3293-307. PubMed ID: 16959876
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
